BRIEF

on Frequency Exchange Corp. (isin : CA3580191078)

Frequency Exchange Corp. Highlights Success at ECO24 Event

Frequency Exchange Corp., through its subsidiary FREmedica Technologies Inc., successfully presented at the ECO24 Event in Dallas, Texas. This event, hosted by CellCore Biosciences, is notable for gathering 1,500 professionals focused on frequency and Lyme disease management. FREmedica introduced its product NIKKI, a personal Frequency Delivery System, to an enthusiastic audience of health experts. The presentation received positive feedback, facilitating numerous affiliations and financial involvement from attending practitioners.

Stephen Davis, CEO of Frequency Exchange Corp., expressed gratitude towards the CellCore team and the doctors present. He commended the event for its familial atmosphere and the collaborative spirit it fostered. The successful demonstration of NIKKI, which targets wellness and Lyme disease management, marked a significant milestone for the company at this prestigious annual meeting.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Frequency Exchange Corp. news